Effectiveness and safety of combined therapy versus monotherapy based on immune checkpoint inhibitors and/or targeted drugs as salvage treatment for advanced urothelial carcinoma: a systematic review and meta-analysis

BACKGROUND: The standard salvage regimen for the patients with advanced urothelial carcinoma (UC) is uncertain, although lots of novel agents are recommended, including immune checkpoint inhibitors (ICIs) and targeted drugs (TDs). We aimed to compare the effectiveness and safety of combined therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Lichao, Gao, Liang, Hu, Zili, Liu, Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797973/
https://www.ncbi.nlm.nih.gov/pubmed/35116530
http://dx.doi.org/10.21037/tcr-20-3354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797973/
https://www.ncbi.nlm.nih.gov/pubmed/35116530
http://dx.doi.org/10.21037/tcr-20-3354

Ejemplares similares